What Criteria Must be Met for Fast Track Designation?
To qualify for fast track designation, a drug must treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs. This can include providing a therapy where none exists or offering a substantial improvement over existing therapies. The drug developer must submit a request to the regulatory body, such as the FDA, showing evidence that the drug meets these criteria.
